“Bone Grafts and Substitutes Market Report is set to have rapid growth due to the factors, such as High awareness regarding the commercially available products, higher healthcare expenditure, and availability of advanced healthcare infrastructure at global, regional and national level, influencing the industry trends in each of the sub-segments from 2019 to 2029”, says Visiongain Report
04 September 2019
Visiongain has launched a new pharma report Bone Grafts and Substitutes Market Report: By Material Type (Natural, Synthetic), By Application Type (Spinal Fusion, Craniomaxillofacial, Long Bone), By Region, And Segment Forecasts
Bone Grafts and substitutes are broadly utilized in orthopedic medical procedures for various applications. Rising instances of orthopedic issues due to weakened bones is forecasted to have higher demand in the coming future, projected from 2019-2029.
According to the United Nations Department of Economic and Social Affairs, Population Division, the number of people over the age of 60 was 841 million in 2013 and is expected to reach 2 billion in 2050. Therefore, the number of orthopedic surgeries it should increase with an increasing geriatric population that is more prone to orthopedic disorders. Therefore, it is expected that the market will see significant demand during the forecast period.
However, the risk of disease transmission and the immune response are the main factors that hinder market growth. Furthermore, the high cost of advanced products and the rigorous regulatory process involved further limit market development. Furthermore, the ethical issues associated with bone harvesting limit market growth in some regions.
The market is divided into global bone graft segments, replacing market reports based on material, application, and region.
Major applications include craniofacial, dentistry, feet and ankles, joint reconstruction, long bones, and spinal fixation. Improved reimbursement scope and the presence of a large elderly patient population are some of the factors that support market growth.
Leading companies featured in the report include: DePuy Synthes; Medtronic PLC; Nuvasive, Inc.; Orthofix Holdings, Inc.; Wright Medical Group N.V.; AlloSource, Inc.; and Stryker Corp.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The biologics market is estimated at US$447 billion in 2023 and is projected to grow at a CAGR of 8.5% during the forecast period 2024-2034.
20 November 2023
The global mRNA Vaccines market is estimated at US$11,773.3 million in 2023 and is projected to grow at a CAGR of 10.5% during the forecast period 2023-2033.
08 November 2023
The global Stem Cell Technologies and Applications market is estimated at US$10,059.6 million in 2023 and is projected to grow at a CAGR of 8.7% during the forecast period 2023-2033.
06 November 2023
The global Neurology Clinical Trials market is valued at US$9,609.2 million in 2023 and is projected to grow at a CAGR of 5.4% during the forecast period 2023-2033.